...
Non-white subjects are underrepresented in phase III trials for psoriasis treatments
September 8, 2020

Plaque psoriasis is a common chronic inflammatory skin disease.  Treatment for plaque psoriasis includes oral systemic, topical, and biologic medications. Although biologic therapies continue to be increasingly utilized in treating moderate-to-severe psoriasis, evidence has shown that non-white ethnicity is associated with a reduced likelihood of responding to biologics up to one year in patients with …

...
Better training and more diversity needed for Patients of Color
September 3, 2019

Within the US, there has been a push to increase racial and ethnic diversity within the dermatology work force. Efforts have also begun to include more racial and ethnic minorities within clinical trials. Providers who work within the field of dermatology have expressed there is a lack of curriculum devoted to the care of skin …